var data={"title":"Lindane: Pediatric drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Lindane: Pediatric drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/6466?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=lindane-drug-information\" class=\"drug drug_general\">see &quot;Lindane: Drug information&quot;</a> and <a href=\"topic.htm?path=lindane-patient-drug-information\" class=\"drug drug_patient\">see &quot;Lindane: Patient drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5709012\" class=\"block black-box-warn drugH1Div\"><span class=\"drugH1\">ALERT: US Boxed Warning</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Appropriate use: </span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:2em;\">Only use lindane in patients who cannot tolerate or have failed first-line treatment with safer medications for the treatment of scabies. Instruct patients on the proper use of lindane, the amount to apply, how long to leave it on, and avoiding re-treatment. Inform patients that itching occurs after the successful killing of scabies and is not necessarily an indication for re-treatment with lindane.</p></div>\r\n</div>\r\n\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Neurologic toxicity:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:2em;\">Seizures and deaths have been reported following lindane use with repeat or prolonged application, but also in rare cases following a single application used according to directions. Exercise caution when using lindane in infants, children, the elderly, and individuals with other skin conditions (eg, atopic dermatitis, psoriasis) and in those who weigh less than 110 lbs (50 kg) as they may be at risk of serious neurotoxicity.</p></div>\r\n</div>\r\n\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Pediatrics:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:2em;\">Lindane is contraindicated in premature infants and individuals with known uncontrolled seizure disorders.</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1048263\" class=\"list_set htclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Therapeutic Category</span>\n    <ul>\n      <li>\n        <span class=\"list-set-name\">Antiparasitic Agent, Topical</span>;</li>\n      <li>\n        <span class=\"list-set-name\">Pediculocide</span>;</li>\n      <li>\n        <span class=\"list-set-name\">Scabicidal Agent</span>;</li>\n      <li>\n        <span class=\"list-set-name\">Shampoos</span></li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1048258\" class=\"block dos drugH1Div\"><span class=\"drugH1\">Dosing: Usual</span><p>(For additional information <a href=\"topic.htm?path=lindane-drug-information\" class=\"drug drug_general\">see &quot;Lindane: Drug information&quot;</a>)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Infants, Children, and Adolescents: <b>Note:</b> The AAP no longer recommends lindane as a treatment option for head lice or scabies in pediatric patients due to safety concerns (<i>Red Book</i>, 2012); use extreme caution in infants, children, and adolescents weighing &lt; 50 kg.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Head lice:</b> Shampoo: Topical: Apply shampoo to dry hair and massage into hair for 4 minutes. Add small amounts of water to form lather, then immediately rinse lather away.  Amount of shampoo needed is based on length and density of hair; most patients require &le;30 mL; maximum dose: 60 mL. Do not retreat.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Scabies:</b> Lotion: Topical: Apply a thin layer of lotion and massage it on skin from the neck to the toes. Most patients require &le;30 mL; maximum dose: 60 mL. Do not retreat.  Do not leave on for more than 12 hours.</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Infants and Children: Wash off 6 hours after application (Pramanik, 1979)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Adults:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Head lice, crab lice:</b> Topical: Apply shampoo to dry hair and massage into hair for 4 minutes; add small quantities of water to hair until lather forms, then rinse hair thoroughly and comb with a fine tooth comb to remove nits. Amount of shampoo needed is based on length and density of hair; most patients will require 30 mL (maximum: 60 mL). Do not retreat.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Scabies:</b> Topical: Apply a thin layer of lotion and massage it on skin from the neck to the toes; after 8-12 hours; bathe and remove the drug; most patients will require 30 mL; larger adults may require up to 60 mL. Do not retreat. Do not leave on for more than 12 hours. </p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dosing adjustment in renal impairment:</b> There are no dosage adjustments provided in the manufacturer's labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dosing adjustment in hepatic impairment:</b> There are no dosage adjustments provided in the manufacturer's labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F24520158\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Lotion, External: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 1% (60 mL [DSC])</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Shampoo, External: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 1% (60 mL)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F188850\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Availability (US)</span>\n    <p style=\"text-indent:0em;display:inline\">Yes</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50511172\" class=\"block prod-avail drugH1Div\"><span class=\"drugH1\">Product Availability</span>\n    <p style=\"text-indent:0em;display:inline\">Lindane lotion has been discontinued in the US for more than 1 year.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7874687\" class=\"block meg drugH1Div\"><span class=\"drugH1\">Medication Guide and/or Vaccine Information Statement (VIS)</span>\n    <p style=\"text-indent:0em;display:inline\">An FDA-approved patient medication guide, which is available with the product information and as follows, must be dispensed with this medication:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;\">Lindane lotion: <a target=\"_blank\" href=\"http://www.fda.gov/downloads/Drugs/DrugSafety/UCM133687.pdf&amp;token=SHauxSdf9qNc6lLK16E8IL3aNdSXbSTKjKzr5jWxn/+nIf162NgDrXSMpjxmnBPQtwtfTRsL5FyqHdG6ks4AWA==&amp;TOPIC_ID=12554\">http://www.fda.gov/downloads/Drugs/DrugSafety/UCM133687.pdf</a></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Lindane shampoo:  <a target=\"_blank\" href=\"http://www.fda.gov/downloads/Drugs/DrugSafety/UCM133688.pdf&amp;token=SHauxSdf9qNc6lLK16E8IL3aNdSXbSTKjKzr5jWxn/+nIf162NgDrXSMpjxmnBPQDAGDngWsdLRB1t9OS8EGXg==&amp;TOPIC_ID=12554\" target=\"_blank\">http://www.fda.gov/downloads/Drugs/DrugSafety/UCM133688.pdf</a>.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1048266\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Shake well prior to use. For topical use only; never administer orally. Caregivers should apply with gloves (avoid natural latex, may be permeable to lindane). Rinse off with warm (not hot) water. </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Lotion: Apply to dry, cool skin; do not apply to face or eyes. In infants when treating scabies, medication should be applied head to toe since those areas may also be affected (CDC, 2010; <i>Red Book</i>, 2012). Before application, wait at least 1 hour after bathing or showering (wet or warm skin increases absorption). Skin should be clean and free of any other lotions, creams, or oil prior to lindane application. Do not use on open wounds or sores. Do not use occlusive dressings (eg, diaper). Trim nails prior to use and apply under fingernails.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Shampoo: Apply to clean, dry hair. Wait at least 1 hour after washing and drying hair before applying lindane shampoo. Hair should be washed with a shampoo not containing a conditioner; hair and skin of head and neck should be free of any lotions, oils, or creams prior to lindane application. Do not cover with shower cap or towel. </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F49132644\" class=\"block hazard drugH1Div\"><span class=\"drugH1\">Hazardous Drugs Handling Considerations</span>\n    <p style=\"text-indent:0em;\">Hazardous agent; use appropriate precautions for handling and disposal (EPA, U-listed).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F20403060\" class=\"block sts drugH1Div\"><span class=\"drugH1\">Storage/Stability</span>\n    <p style=\"text-indent:0em;display:inline\">Store at 20&deg;C to 25&deg;C (68&deg;F to 77&deg;F).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1048265\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Lotion: Second-line treatment of scabies (<i>Sarcoptes scabiei</i>) in patients intolerant to or who have failed other treatment options [FDA approved in pediatric patients (age not specified) and adults]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Shampoo: Second-line treatment of <i>Pediculus humanus capitis</i> (head lice), and <i>Pthirus pubis</i> (crab lice) and their ova  in patients intolerant to or who have failed other treatment options [FDA approved in pediatric patients (age not specified) and adults]</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F188922\" class=\"block arm drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:0em;display:inline\">Frequency not defined.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Central nervous system: Ataxia, dizziness, localized burning, neurotoxicity (risk greater in patients &lt;110 lbs [50 kg]), restlessness, seizure, stinging sensation</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Dermatologic: Contact dermatitis, eczematous rash</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Hematologic &amp; oncologic: Aplastic anemia (CDC 2010)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Rare but important or life-threatening: Alopecia, dermatitis, headache, pain, paresthesia, pruritus, urticaria</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F188870\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">Hypersensitivity to lindane or any component of the formulation; premature infants; uncontrolled seizure disorders; crusted (Norwegian) scabies or other skin conditions (eg, atopic dermatitis, psoriasis) which may increase systemic absorption</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F188854\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Neurotoxicity: <b>[US Boxed Warning]: May be associated with severe neurologic toxicities. Seizures and death have been reported with use (may occur with prolonged, repeated, or single use). Use is contraindicated in patients with uncontrolled seizure disorders and in premature infants. Use with caution in infants, small children, the elderly, patients with other skin conditions, patients weighing &lt;50 kg, </b> or patients with a history of seizures, head trauma, or HIV infection; use caution with conditions which may increase risk of seizures or medications which decrease seizure threshold.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Disease-related concerns:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Hepatic impairment: Use with caution in patients with hepatic impairment.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Special populations:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Pediatric: <b>[US Boxed Warning]: Use is contraindicated in premature infants;</b> the skin of premature infants may be more permeable and their liver enzymes may not be fully developed when compared to full-term infants.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Other warnings/precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Appropriate use: <b>[US Boxed Warning]: Not a drug of first choice; use only in patients who have failed or cannot tolerate first-line agents. Instruct patients on proper use, including the amount to apply, how long to leave on, and to avoid re-treatment. Itching may occur as a result of killing lice and does not necessarily indicate treatment failure or need for re-treatment.</b> Because of the potential for systemic absorption and CNS side effects, lindane should be used with caution; consider permethrin or crotamiton agent first. Oil-based hair dressing may increase toxic potential. For external use only; avoid contact with face, eyes, mucous membranes, and urethral meatus. For treatment only; not to be used to prevent infestation. Should be used as a part of an overall lice management program.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F26022239\" class=\"block add-pediatric-warn-info drugH1Div\"><span class=\"drugH1\">Warnings: Additional Pediatric Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Risk of neurologic toxicities increased in infants, children, and patients &lt;50 kg compared to the elderly. Use is contraindicated in premature infants and patients with uncontrolled seizure disorders. Premature infants may have increased systemic exposure due to increased permeability of skin, larger skin surface area to volume ratio, and immature hepatic development compared to full-term infants. Use with caution in patients with a history of seizures, head trauma, HIV infection, or with conditions which may increase risk of seizures or medications which decrease seizure threshold. When lotion is used in small infants and young children, cover hands to prevent accidental lindane ingestion from thumbsucking; consider alternative therapy for the treatment of scabies in infants and young children &lt;2 years of age (ie, permethrin). Due to availability of other effective treatments, lindane is no longer recommended for the treatment of scabies or lice in pediatric patients (Frankowski 2010;<i> Red Book</i> [AAP] 2012). Excessive absorption may result in overdose with signs and symptoms which include nausea, vomiting, seizures, headaches, arrhythmias, apnea, pulmonary edema, hematuria, hepatitis, coma, and even death (Pramanik 1979; Singal 2006)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13299605\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F188859\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=12554&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:0em;display:inline\">There are no known significant interactions.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F188860\" class=\"block prf drugH1Div\"><span class=\"drugH1\">Pregnancy Risk Factor</span>\n    <p style=\"text-indent:0em;display:inline\">C (<a href=\"image.htm?imageKey=DRUG%2F50021\" class=\"graphic graphic_table\">show table</a>)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F188872\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Adverse events have been observed in animal reproduction studies. Animal studies suggest possible neurologic abnormalities due to the increased susceptibility of drug and the immature central nervous system of the fetus. Lindane is lipophilic and may accumulate in the placenta. Use in pregnant women has been associated with neural tube defects and mental retardation (CDC [Workowski 2015]).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F188853\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Directly absorbed by parasites and ova through the exoskeleton; stimulates the nervous system resulting in seizures and death of parasitic arthropods</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F188869\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics (Adult data unless noted)</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Absorption: ~10% systemically; absorption higher when applied to weeping or excoriated skin (Ginsburg 1977)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Metabolism: Hepatic</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Half-life elimination: Infants &ge;5 months and Children &le;8 years (Ginsburg 1977): Healthy skin: 21.4 hours; Infected skin: 17.9 hours</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Time to peak, serum: Infants &ge;5 months and Children: 6 hours</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Excretion: Urine and feces</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F16323319\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Shampoo</b> (Lindane External)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1% (60 mL): $136.86</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F188874\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Agalin (PL);</li>\n      <li>Aphtiria (FR);</li>\n      <li>Aprurol (UY);</li>\n      <li>Ascabiol (IN);</li>\n      <li>Benhex Cream (NZ);</li>\n      <li>Bexarid (IN);</li>\n      <li>Davesol (EC);</li>\n      <li>Delice (TW);</li>\n      <li>Delitex (DE);</li>\n      <li>Demar (VE);</li>\n      <li>Desintan (FI, GB);</li>\n      <li>Elentol (FR);</li>\n      <li>Esoderm (AE);</li>\n      <li>GAB (IN);</li>\n      <li>Gama Acaderm (CL);</li>\n      <li>Gambex (ZA);</li>\n      <li>Gamma-Scab (AR);</li>\n      <li>Gatox (HR);</li>\n      <li>GBHC (IN);</li>\n      <li>Herklin (MX);</li>\n      <li>Hexa-Defital (AR);</li>\n      <li>Hexin (TH);</li>\n      <li>Jacutin (CH, CZ, DE, HN, LU, PL, SG);</li>\n      <li>Kwell (AE, KW, QA, SA);</li>\n      <li>Kwellada (GR);</li>\n      <li>Lencid (BE, LU);</li>\n      <li>Lendianon (BR);</li>\n      <li>Lindan (ID);</li>\n      <li>Lindano (AR);</li>\n      <li>Lindano-GBHG (PY);</li>\n      <li>Linden Lotion (KR);</li>\n      <li>Milinor (HR);</li>\n      <li>Nedax (BR);</li>\n      <li>Paracid (BE);</li>\n      <li>Parakil (LB);</li>\n      <li>Plomurol (CL);</li>\n      <li>Pruritrat (BR);</li>\n      <li>Quellada (BE, IE, LU);</li>\n      <li>Quellada Cream (AU);</li>\n      <li>Quellada Creme Rinse (AU);</li>\n      <li>Quellada Head Lice Treatment (AU);</li>\n      <li>Quellada Lotion (AU);</li>\n      <li>Sarcoderma (PT);</li>\n      <li>Scabcur (LK);</li>\n      <li>Scabecid (FR);</li>\n      <li>Scabene (PK);</li>\n      <li>Scabi (TW);</li>\n      <li>Scabix (BR);</li>\n      <li>Scaboma (LK, MY, VN);</li>\n      <li>Skabicid (CZ);</li>\n      <li>Somergan (VE);</li>\n      <li>Texa (BE)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    American Academy of Pediatrics (AAP). In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds. <i>Red Book: 2012 Report of the Committee on Infectious Diseases</i>. 29th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2012.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for  Disease Control and Prevention (CDC). Scabies - treatment. November 3, 2011. Available at <a href=\"http://www.cdc.gov/parasites/scabies/treatment.html\" target=\"_blank\">http://www.cdc.gov/parasites/scabies/treatment.html</a></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control and Prevention (CDC), &quot;Sexually Transmitted Diseases Treatment Guidelines, 2010,&quot; <i>MMWR Recomm Rep</i>, 2010, 59(RR-12):1-110. <span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/lindane-pediatric-drug-information/abstract-text/21160459/pubmed\" target=\"_blank\" id=\"21160459\">21160459</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Frankowski BL, Bocchini JA Jr, and Council on School Health and Committee on Infectious Diseases, &quot;Head Lice,&quot; <i>Pediatrics</i>, 2010, 126(2):392-403.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/lindane-pediatric-drug-information/abstract-text/20660553/pubmed\" target=\"_blank\" id=\"20660553\">20660553</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Ginsburg CM, Lowry W, and Reisch JS, &quot;Absorption of Lindane (Gamma Benzene Hexachloride) in Infants and Children,&quot; <i>J Pediatr</i>, 1977, 91(6):998-1000.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/lindane-pediatric-drug-information/abstract-text/72815/pubmed\" target=\"_blank\" id=\"72815\">72815</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Healthcare Environmental Resource Center (HERC). Pharmaceuticals&mdash;Hazardous Waste. &lt;web-link url=&quot;http://www.hercenter.org/hazmat/pharma.cfm#listed&quot; window=&quot;new&quot;&gt;http://www.hercenter.org/hazmat/pharma.cfm#listed&lt;/web-link&gt;. Published 2015. Accessed October 23, 2016.&lt;/reference&gt;&lt;reference&gt;Amphotericin B [prescribing information]. Big Flats, NY: X-Gen Pharmaceuticals; April 2010.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Pramanik AK and Hansen RC, &ldquo;Transcutaneous Gamma Benzene Hexachloride Absorption and Toxicity in Infants and Children,&rdquo; <i>Arch Dermatol</i>, 1979, 115(10):1224-5.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/lindane-pediatric-drug-information/abstract-text/92217/pubmed\" target=\"_blank\" id=\"92217\">92217</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 12554 Version 94.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"ALERT: US Boxed Warning\" href=\"#F5709012\" class=\"outlineLink\">ALERT: US Boxed Warning</a></li><li class=\"plainItem\"><a sectionName=\"Therapeutic Category\" href=\"#F1048263\" class=\"outlineLink\">Therapeutic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Usual\" href=\"#F1048258\" class=\"outlineLink\">Dosing: Usual</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F24520158\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Availability (US)\" href=\"#F188850\" class=\"outlineLink\">Generic Availability (US)</a></li><li class=\"plainItem\"><a sectionName=\"Product Availability\" href=\"#F50511172\" class=\"outlineLink\">Product Availability</a></li><li class=\"plainItem\"><a sectionName=\"Medication Guide and/or Vaccine Information Statement (VIS)\" href=\"#F7874687\" class=\"outlineLink\">Medication Guide and/or Vaccine Information Statement (VIS)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F1048266\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Hazardous Drugs Handling Considerations\" href=\"#F49132644\" class=\"outlineLink\">Hazardous Drugs Handling Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Storage/Stability\" href=\"#F20403060\" class=\"outlineLink\">Storage/Stability</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F1048265\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F188922\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F188870\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F188854\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Warnings: Additional Pediatric Considerations\" href=\"#F26022239\" class=\"outlineLink\">Warnings: Additional Pediatric Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F13299605\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F188859\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Risk Factor\" href=\"#F188860\" class=\"outlineLink\">Pregnancy Risk Factor</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F188872\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F188853\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics (Adult data unless noted)\" href=\"#F188869\" class=\"outlineLink\">Pharmacodynamics/Kinetics (Adult data unless noted)</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F16323319\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F188874\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_PED/12554|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=lindane-drug-information\" class=\"drug drug_general\">Lindane: Drug information</a></li><li><a href=\"topic.htm?path=lindane-patient-drug-information\" class=\"drug drug_patient\">Lindane: Patient drug information</a></li></ul></div></div>","javascript":null}